195 related articles for article (PubMed ID: 11044557)
1. Effect of an intravitreal cyclosporine implant on experimental uveitis in horses.
Gilger BC; Malok E; Stewart T; Horohov D; Ashton P; Smith T; Jaffe GJ; Allen JB
Vet Immunol Immunopathol; 2000 Oct; 76(3-4):239-55. PubMed ID: 11044557
[TBL] [Abstract][Full Text] [Related]
2. Intravitreal sustained-release cyclosporine in the treatment of experimental uveitis.
Jaffe GJ; Yang CS; Wang XC; Cousins SW; Gallemore RP; Ashton P
Ophthalmology; 1998 Jan; 105(1):46-56. PubMed ID: 9442778
[TBL] [Abstract][Full Text] [Related]
3. Use of an intravitreal sustained-release cyclosporine delivery device for treatment of equine recurrent uveitis.
Gilger BC; Wilkie DA; Davidson MG; Allen JB
Am J Vet Res; 2001 Dec; 62(12):1892-6. PubMed ID: 11763177
[TBL] [Abstract][Full Text] [Related]
4. Long-term effect on the equine eye of an intravitreal device used for sustained release of cyclosporine A.
Gilger BC; Malok E; Stewart T; Ashton P; Smith T; Jaffe GJ; Allen JB
Vet Ophthalmol; 2000; 3(2-3):105-110. PubMed ID: 11397291
[TBL] [Abstract][Full Text] [Related]
5. [Intraocular implantation of cyclosporine A drug delivery system in the treatment of experimental uveitis].
Dong XG; Xu YM; Yuan GQ; Shi WY; Xie LX; Wang SG
Zhonghua Yan Ke Za Zhi; 2005 Jul; 41(7):636-41. PubMed ID: 16080900
[TBL] [Abstract][Full Text] [Related]
6. A novel bioerodible deep scleral lamellar cyclosporine implant for uveitis.
Gilger BC; Salmon JH; Wilkie DA; Cruysberg LP; Kim J; Hayat M; Kim H; Kim S; Yuan P; Lee SS; Harrington SM; Murray PR; Edelhauser HF; Csaky KG; Robinson MR
Invest Ophthalmol Vis Sci; 2006 Jun; 47(6):2596-605. PubMed ID: 16723476
[TBL] [Abstract][Full Text] [Related]
7. Scleral plug of biodegradable polymers containing tacrolimus (FK506) for experimental uveitis.
Sakurai E; Nozaki M; Okabe K; Kunou N; Kimura H; Ogura Y
Invest Ophthalmol Vis Sci; 2003 Nov; 44(11):4845-52. PubMed ID: 14578407
[TBL] [Abstract][Full Text] [Related]
8. Characterization of T-lymphocytes in the anterior uvea of eyes with chronic equine recurrent uveitis.
Gilger BC; Malok E; Cutter KV; Stewart T; Horohov DW; Allen JB
Vet Immunol Immunopathol; 1999 Oct; 71(1):17-28. PubMed ID: 10522783
[TBL] [Abstract][Full Text] [Related]
9. Long-term outcome after implantation of a suprachoroidal cyclosporine drug delivery device in horses with recurrent uveitis.
Gilger BC; Wilkie DA; Clode AB; McMullen RJ; Utter ME; Komaromy AM; Brooks DE; Salmon JH
Vet Ophthalmol; 2010 Sep; 13(5):294-300. PubMed ID: 20840106
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal implantation of the biodegradable cyclosporin A drug delivery system for experimental chronic uveitis.
Dong X; Shi W; Yuan G; Xie L; Wang S; Lin P
Graefes Arch Clin Exp Ophthalmol; 2006 Apr; 244(4):492-7. PubMed ID: 16163496
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic and toxicological evaluations of cyclosporine a microspheres as a treatment vehicle for uveitis in rabbits.
He Y; Wang JC; Liu YL; Ma ZZ; Zhu XA; Zhang Q
J Ocul Pharmacol Ther; 2006 Apr; 22(2):121-31. PubMed ID: 16722798
[TBL] [Abstract][Full Text] [Related]
12. Cytokine and chemokine profiles of aqueous humor and serum in horses with uveitis measured using multiplex bead immunoassay analysis.
Curto E; Messenger KM; Salmon JH; Gilger BC
Vet Immunol Immunopathol; 2016 Dec; 182():43-51. PubMed ID: 27863549
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal injection of low-dose gentamicin for the treatment of recurrent or persistent uveitis in horses: Preliminary results.
Fischer BM; McMullen RJ; Reese S; Brehm W
BMC Vet Res; 2019 Jan; 15(1):29. PubMed ID: 30651102
[TBL] [Abstract][Full Text] [Related]
14. Immunological and pathological investigations in equine experimental uveitis.
Simeonova GP; Krastev SZ; Simeonov RS
Vet Res Commun; 2016 Dec; 40(3-4):107-115. PubMed ID: 27344152
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of low-release-rate fluocinolone acetonide intravitreal implants to treat experimental uveitis.
Mruthyunjaya P; Khalatbari D; Yang P; Stinnett S; Tano R; Ashton P; Guo H; Nazzaro M; Jaffe GJ
Arch Ophthalmol; 2006 Jul; 124(7):1012-8. PubMed ID: 16832025
[TBL] [Abstract][Full Text] [Related]
16. Intravitreal sustained-release dexamethasone device in the treatment of experimental uveitis.
Cheng CK; Berger AS; Pearson PA; Ashton P; Jaffe GJ
Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):442-53. PubMed ID: 7843913
[TBL] [Abstract][Full Text] [Related]
17. [Effects of leflunomide on experimental autoimmune uveitis in Lewis rats].
Fang C; Zhou D; Zhan S; He Y; Lin Z; Huang C; Li J
Zhonghua Yan Ke Za Zhi; 2015 Oct; 51(10):754-61. PubMed ID: 26693771
[TBL] [Abstract][Full Text] [Related]
18. Expression of a chemokine by ciliary body epithelium in horses with naturally occurring recurrent uveitis and in cultured ciliary body epithelial cells.
Gilger BC; Yang P; Salmon JH; Jaffe GJ; Allen JB
Am J Vet Res; 2002 Jul; 63(7):942-7. PubMed ID: 12118672
[TBL] [Abstract][Full Text] [Related]
19. Use of Intravitreal Injection of Gentamicin in 71 Horses With Equine Recurrent Uveitis.
Launois T; González Hilarión LM; Barbe F; Leurquin C; Bihin B; Hontoir F; Dugdale A; Vandeweerd JM
J Equine Vet Sci; 2019 Jun; 77():93-97. PubMed ID: 31133325
[TBL] [Abstract][Full Text] [Related]
20. Immunologic and virologic characterization of the primary infiltrating cells in the aqueous humor of human T-cell leukemia virus type-1 uveitis. Accumulation of the human T-cell leukemia virus type-1-infected cells and constitutive expression of viral and interleukin-6 messenger ribonucleic acids.
Ono A; Mochizuki M; Yamaguchi K; Miyata N; Watanabe T
Invest Ophthalmol Vis Sci; 1997 Mar; 38(3):676-89. PubMed ID: 9071222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
